FAP immunosuppressive CAR-DC: Clinical Trials

2 trials of FAP immunosuppressive CAR-DC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 21Recruiting 1

Follow FAP immunosuppressive CAR-DC: new trials by email Literature Review of FAP immunosuppressive CAR-DC trials Research Report on FAP immunosuppressive CAR-DC

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine52026-05-112026-07-02
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1 / Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine432025-04-222026-07-14

Conditions studied

Cardiomyopathy, Dilated (2)  ·  Heart Failure (2)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (2)

Countries

China (2)

Top investigators

Xinyang Hu, PhD (2)